EQ•benzinga•
Equillium Announced That Ono Pharmaceutical Has Made The Strategic Business Decision To Allow Its Option To Acquire Equillium's Rights To Itolizumab To Expire
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on October 31, 2024 by benzinga